Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Barry

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Transplantation|October 1, 1988
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejectionD J Norman, C F Shield, K R Henell, et al.
Urology|September 8, 1998
Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular SurgeryB R Konety, A Tewari, R J Howard, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 1, 1994
A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantationD J Norman, J A Kimball, W M Bennett, et al.
Journal of Cardiovascular Risk|September 29, 1999
Factors in cardiac risk stratification of candidates for renal transplantM S Lewis, R A Wilson, K Walker, et al.
Transplantation Proceedings|February 1, 1991
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low dosesD J Norman, J M Barry, W M Bennett, et al.
Urology|May 1, 1980
Percutaneous aspiration biopsy of renal allografts using ultrasound localizationR A Parker, W C Elliott, R S Muther, et al.
Transplantation|October 1, 1993
Fate of renal allografts transplanted in patients with urinary diversionD A Hatch, P Belitsky, J M Barry, et al.
Clinical Transplants|January 1, 1991
Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990D J Norman, W M Bennett, P J Wetzsteon, et al.
Transplantation|January 11, 2001
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donorsD J Norman, F Vincenti, A M de Mattos, et al.
Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Transplantation|October 1, 1988
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejectionD J Norman, C F Shield, K R Henell, et al.
Urology|September 8, 1998
Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular SurgeryB R Konety, A Tewari, R J Howard, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 1, 1994
A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantationD J Norman, J A Kimball, W M Bennett, et al.
Journal of Cardiovascular Risk|September 29, 1999
Factors in cardiac risk stratification of candidates for renal transplantM S Lewis, R A Wilson, K Walker, et al.
Transplantation Proceedings|February 1, 1991
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low dosesD J Norman, J M Barry, W M Bennett, et al.
Urology|May 1, 1980
Percutaneous aspiration biopsy of renal allografts using ultrasound localizationR A Parker, W C Elliott, R S Muther, et al.
Transplantation|October 1, 1993
Fate of renal allografts transplanted in patients with urinary diversionD A Hatch, P Belitsky, J M Barry, et al.
Clinical Transplants|January 1, 1991
Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990D J Norman, W M Bennett, P J Wetzsteon, et al.
Transplantation|January 11, 2001
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donorsD J Norman, F Vincenti, A M de Mattos, et al.
Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.
Pageof 21